Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Recent insights into the actions of IGFBP-6.

Bach LA.

J Cell Commun Signal. 2015 Jun;9(2):189-200. doi: 10.1007/s12079-015-0288-4. Epub 2015 Mar 26.

2.

Prohibitin 2 regulates the proliferation and lineage-specific differentiation of mouse embryonic stem cells in mitochondria.

Kowno M, Watanabe-Susaki K, Ishimine H, Komazaki S, Enomoto K, Seki Y, Wang YY, Ishigaki Y, Ninomiya N, Noguchi TA, Kokubu Y, Ohnishi K, Nakajima Y, Kato K, Intoh A, Takada H, Yamakawa N, Wang PC, Asashima M, Kurisaki A.

PLoS One. 2014 Apr 7;9(4):e81552. doi: 10.1371/journal.pone.0081552. eCollection 2014.

3.

Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity.

Begum A, Lin Q, Yu C, Kim Y, Yun Z.

Mol Cancer Res. 2014 Jan;12(1):155-64. doi: 10.1158/1541-7786.MCR-13-0360. Epub 2013 Nov 18.

4.

Characterization of the Akt2 domain essential for binding nuclear p21cip1 to promote cell cycle arrest during myogenic differentiation.

Heron-Milhavet L, Franckhauser C, Fernandez A, Lamb NJ.

PLoS One. 2013 Oct 23;8(10):e76987. doi: 10.1371/journal.pone.0076987. eCollection 2013.

5.

Protein phosphatase 2A isoforms utilizing Aβ scaffolds regulate differentiation through control of Akt protein.

Hwang JH, Jiang T, Kulkarni S, Faure N, Schaffhausen BS.

J Biol Chem. 2013 Nov 1;288(44):32064-73. doi: 10.1074/jbc.M113.497644. Epub 2013 Sep 19.

6.

Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.

Fu P, Yang Z, Bach LA.

J Biol Chem. 2013 Oct 11;288(41):29890-900. doi: 10.1074/jbc.M113.510826. Epub 2013 Sep 3.

7.
8.

Mitochondrial dysfunction and adipogenic reduction by prohibitin silencing in 3T3-L1 cells.

Liu D, Lin Y, Kang T, Huang B, Xu W, Garcia-Barrio M, Olatinwo M, Matthews R, Chen YE, Thompson WE.

PLoS One. 2012;7(3):e34315. doi: 10.1371/journal.pone.0034315. Epub 2012 Mar 30.

9.

Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Wani R, Bharathi NS, Field J, Tsang AW, Furdui CM.

Cell Cycle. 2011 Oct 1;10(19):3263-8. doi: 10.4161/cc.10.19.17738. Epub 2011 Oct 1.

10.

The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.

Knight JD, Kothary R.

Skelet Muscle. 2011 Sep 8;1:29. doi: 10.1186/2044-5040-1-29.

11.

Roles of prohibitin in growth control and tumor suppression in human cancers.

Wang S, Faller DV.

Transl Oncogenomics. 2008 Feb 10;3:23-37.

12.

Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Fluck MM, Schaffhausen BS.

Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents. doi: 10.1128/MMBR.00009-09. Review.

13.

The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.

Shu L, Houghton PJ.

Mol Cell Biol. 2009 Sep;29(17):4691-700. doi: 10.1128/MCB.00764-09. Epub 2009 Jun 29.

14.

Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation.

Rotwein P, Wilson EM.

J Cell Physiol. 2009 May;219(2):503-11. doi: 10.1002/jcp.21692.

15.

Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.

Gayer CP, Chaturvedi LS, Wang S, Craig DH, Flanigan T, Basson MD.

J Biol Chem. 2009 Jan 23;284(4):2001-11. doi: 10.1074/jbc.M804576200. Epub 2008 Dec 1.

16.

Inhibition of myogenesis by Notch: evidence for multiple pathways.

Buas MF, Kabak S, Kadesch T.

J Cell Physiol. 2009 Jan;218(1):84-93. doi: 10.1002/jcp.21571.

Supplemental Content

Support Center